Johnson & Johnson (JNJ) is listed on NYSE in the Manufacturing sector. This page tracks real-time JNJ price, technical indicators including RSI, MACD, and the 52-week range, plus fundamentals, earnings history, and recent insider trading activity.
Technical Analysis
RSI (14) 51.9 Neutral
Market Cap $628.7B
Volume 3.6M
Fundamentals — 10-Q Q2 2026
Revenue $49.4B
Net Income $10.8B
EPS $4.41
Gross Margin 67.3%
Net Margin 21.8%
Debt / Equity 0.4x
P/E Ratio 59.2x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Forminard Elizabeth | EVP, Chief Legal Officer | Sell | 15,918 | $257.00 | $4.1M | 2026 Aug 6 |
| Duato Joaquin | CEO and Chairman of the Board | Sell | 48,480 | $258.15 | $12.5M | 2026 Aug 5 |
| Broadhurst Vanessa | EVP, Global Corp Affairs | Sell | 23,054 | $251.27 | $5.8M | 2026 Jul 20 |
| Wengel Kathryn E | EVP, Chief TO and Risk Officer | Sell | 10,000 | $241.15 | $2.4M | 2026 Jun 11 |
| Decker Robert J | VP Corporate Controller | Sell | 4,075 | $247.87 | $1.0M | 2026 Feb 27 |
| Schmid Timothy | EVP, WW Chair, MedTech | Sell | 1,322 | $245.66 | $324,763 | 2026 Feb 20 |
| Morikis John G | Director | Buy | 1,250 | $206.15 | $257,688 | 2025 Nov 26 |
| Reed John C | EVP, Innovative Medicine, R&D | Sell | 21,721 | $192.71 | $4.2M | 2025 Oct 17 |
| Taubert Jennifer L | EVP, WWC. Innovative Medicine | Sell | 56,471 | $177.81 | $10.0M | 2025 Sep 4 |
| Duato Joaquin | CEO and Chairman of the Board | Sell | 125,824 | $179.21 | $22.5M | 2025 Aug 22 |
| Wolk Joseph J | Exec VP, CFO | Sell | 16,820 | $176.91 | $3.0M | 2025 Aug 15 |
| Reed John C | EVP, Innovative Medicine, R&D | Sell | 19,137 | $163.55 | $3.1M | 2025 Jul 17 |
| Decker Robert J | VP Corporate Controller | Sell | 6,999 | $165.88 | $1.2M | 2025 Feb 25 |
| Schmid Timothy | EVP, WW Chair, MedTech | Sell | 403 | $156.15 | $62,928 | 2025 Feb 18 |
| Wolk Joseph J | Exec VP, CFO | Sell | 13,015 | $153.89 | $2.0M | 2025 Feb 7 |
| Weinberger Mark A | Director | Buy | 1,000 | $147.22 | $147,220 | 2024 Dec 12 |
| Decker Robert J | VP Corporate Controller | Sell | 5,635 | $165.06 | $930,113 | 2024 Aug 30 |
| Broadhurst Vanessa | EVP, Global Corp Affairs | Sell | 8,891 | $162.16 | $1.4M | 2024 Mar 13 |
| Taubert Jennifer L | EVP, WW Chair, Pharmaceuticals | Sell | 59,397 | $156.27 | $9.3M | 2024 Feb 9 |
| Hait William | Officer | Sell | 14,698 | $172.00 | $2.5M | 2023 Jul 26 |
Take JNJ further
- Browse Pharmaceutical Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put JNJ in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Johnson & Johnson next reports.
Set alerts on JNJ
Get notified when Johnson & Johnson hits your price targets or technical conditions are met.
Get Started Free